Analysis of the clinical features of pulmonary disease caused by mycobacterium szulgai - A review of 12 cases over 10 years and the utility of drug-susceptibility testing

Kekkaku

Volumn 87, Issue 5, 2012, Pages 391-396

  Sasaki, Yumiko ^a   Suzuki, Katsuhiro ^a   Tsuyuguchi, Kazunari ^a   Yoshida, Shiomi ^a   Tomita, Motohisa ^a   Okada, Masaji ^a   Hayashi, Seiji ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Brothmic NTM; Clarithromycin; Gastroesophageal disorders; Mycobacterium szulgai; Nontuberculous mycobacteria

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; FEMALE; HUMAN; LUNG DISEASE; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; RETROSPECTIVE STUDIES;

EID: 84865151628     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Marks J, Jenkins PA, Tsukamura M: Mycobacterium szulgai -A new pathogen. Tubercle. 1972; 53 : 210-214.
2. Tsuyuguchi K, Amitani R, Matsumoto H, et al.: A resected case of Mycobacterium szulgai pulmonary disease. Int J Tuberc Lung Dis. 1998; 2 : 258-260.
3. Nakayama S, Fujii T, Kadota J, et al.: Pulmonary Myco- bacteriosis caused by Rifampicin-resistant Mycobacterium szulgai. Interal Medicine. 2000; 39 : 309-312.
4. Woods GL, Brown-Elliott BA, Conville PS, et al.: Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, 2nd ed. (M24- A2). 2011, Vol. 31, No.5.
5. Yamamoto M: Pulmonary Disease due to Mycobacterium szulgai in Japan. Internal Medicine. 2000; 39 : 277-279.
6. Dylewski JS, Zackon HM, Latour AH, et al.: Mycobacterium szulgai: An Unusual Pathogen. Rev Infect Dis. 1987; 9 : 578-580.
7. Griffith DE, Aksamit T, Brown-Elliott B A, et al.: An Official ATS/IDSA Statement : Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases: Am J Respir Crit Care Med. 2007; 175 : 367-416.
8. Koh W-J, Lee JH, Kwon YS, et al.: Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest. 2007; 131 : 1825-1830.
9. Vargese G, Shepherd R, Watt P, et al.: Fatal infection with Mycobacterium fortuitum associated with oesophageal achalasia. Thorax. 1988; 43 : 151-152.
10. Hadjiliadis D, Adlakha A, Prakash UB: Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc. 1999; 74 : 45-51.
11. Heifcts L, Mor N, Vanderkolk J: Mycobacterium avium strains resistant to clarithromycin and azithromycin. Anti- microb Agents Chemother. 1993; 37 : 2364-2370.
12. van Ingen J, Boeree MJ, de Lange WC, et al.: Clinical Relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis. 2008; 46 : 1200-1205.
13. Brown BA, Wallace RJ Jr, Onyi GO, et al.: Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother. 1992; 36: 1987-1990.
14. Fernandes PB, Hardy DJ, Mcdaniel D, et al.: In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother. 1989; 33 : 1531- 1534.
15. Meier A, Kirschner P, Springer B, et al.: Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellular. Antimicrob Agents Chemother. 1994;38:381-384.
16. Griffith DE, Girard WM, Wallace RJ Jr.: Clinical features of pulmonary disease caused by rapidly growing mycobacteria: An analysis of 154 patients. Am Rev Respir Dis. 1993; 147: 1271-1278.
17. Pulik M, Leturdu F, Lionnet F, et al.: Mycobacterium szul- gai osteomyelitis in AIDS. Med Mai Infect. 1996; 26 : 674-675.
18. Tortoli E, Besozzi G, Lacchini C, et al.: Pulmonary infection due to Mycobacterium szulgai: case report and review of the literature. Eur Respir J. 1998; 11: 975-977.